TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recall
FDA recall D-0693-2026 · initiated Apr 8, 2026
Blaine Labs Inc recalled TRIFLUENT PHARMA TRIDERGEL Wound Care Gel in Apr 2026 — an FDA Class II recall (D-0693-2026) because CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated.
May cause temporary or medically reversible harm; low probability of serious harm.
Why it was recalled
CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
Something got into the product
A physical or chemical contaminant was found — glass or metal fragments, or a solvent that should not be there.
This is a manufacturing or quality failure, not a finding that the medicine is unsafe to take — across every recall we hold, none was issued for that reason. It does not mean the batch was harmless.
Is your product affected? Check the lot number
A recall covers only specific lots. Find the lot number and expiration date on your package and compare them to the affected codes below — if yours is not listed, it was not part of this recall.
Quantity recalled: 519 - 1 oz bottles
Details
- Product
- TRIFLUENT PHARMA TRIDERGEL Wound Care Gel, (Benzalkonium Chloride 0.1%), 1.0 fl oz, (29.6 mL) bottle with long pointy cap, Manufactured for: Trifluent Pharma, LLC. San Antonio, TX 78213. NDC 73352-520-01.
- Recalling company
- Blaine Labs Inc
- Classification
- Class II
- Status
- Ongoing
- Type
- Voluntary: Firm initiated
- Distribution
- Nationwide in the USA
- Initiated
- Apr 8, 2026
- FDA report date
- Jul 8, 2026
Frequently asked
- Was TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recalled?
- Blaine Labs Inc recalled TRIFLUENT PHARMA TRIDERGEL Wound Care Gel in Apr 2026 — an FDA Class II recall (D-0693-2026) because CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated. May cause temporary or medically reversible harm; low probability of serious harm.
- Why was TRIFLUENT PHARMA TRIDERGEL Wound Care Gel recalled?
- Per the FDA enforcement record, the reason for recall D-0693-2026 was: CGMP Deviations: product manufactured in the same facility under the same conditions as the product found to be contaminated
- Is a recalled TRIFLUENT PHARMA TRIDERGEL Wound Care Gel dangerous to take?
- An FDA recall removes specific lots from the market for a defined reason and does not by itself mean the medicine is unsafe for everyone — your specific lot may never have been affected. May cause temporary or medically reversible harm; low probability of serious harm. Check the FDA notice for the affected lot numbers and expiration dates, and ask your pharmacist or doctor before stopping a prescribed medicine. This reproduces public FDA data and is not medical advice.
- Which lots of TRIFLUENT PHARMA TRIDERGEL Wound Care Gel are affected?
- Distributed: Nationwide in the USA. The recall covers these lots — Lot #: BL3435, Exp. 11/06/26. Check the lot number and expiration date on your package against this list; if yours is not listed, it was not part of recall D-0693-2026.